← All Sponsors
SPONSOR

Kamau Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Sickle Cell Disease
NCT04819841 Phase 1, Phase 2
Recruiting

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

Sickle Cell Disease
United States View Trial →